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1. The inhibition of phosphoglucomutase by beryllium has been examined. 2. Inhibition by beryllium does not occur unless a complex-forming agent such as cysteine or imidazole is present. It is therefore similar to activation by magnesium. 3. The inhibition is progressive and the rate follows first-order kinetics, which may be defined by a bimolecular rate constant. 4. In the presence of magnesium the rate of inhibition is less. By using a fixed time for inhibition competition between beryllium and magnesium may be demonstrated. After inhibition has taken place, the addition of magnesium does not reverse it.
It has previously been reported that beryllium inhibits phosphoglucomutase (D -glucose 1,6-diphosphate-D-glucose 1-phosphate phosphotransferase, EC 2.7.5.1) and that this inhibition is less in the presence of magnesium (Cochran, Zerivic & DuBois, 1951) . The inhibitory activity of beryllium against this enzyme has been confirmed (Thomas & Aldridge, 1966 ) and the present paper describes some novel features of the kinetics of the inhibitory process. A preliminary account of this work has been published (Aldridge & Thomas, 1964) .
MATERIALS AND METHODS
Special chemicals. The following chemicals were obtained from the sources indicated: dipotassium glucosel -phosphate, cysteine hydrochloride and BeSO4,4H20 from British Drug Houses Ltd., Poole, Dorset; imidazole from Koch-Light Laboratories Ltd., Colnbrook, Bucks.; crystalline rabbitmuscle phosphoglucomutase from C. F. Boehringer und Soehne G.m.b.H., Mannheim, Germany.
Determination of phosphoglucomutase. The method used was essentially that of . The final composition of the medium was: cysteine (25mM), MgSO4 (1.5mM), glucose 1-phosphate (1-1-8mM), pH7-4; the total volume was 1-6-2-0ml. The progress of the reaction was followed at 300 by the determination of the acid-labile phosphorus (3min. at 1000 in N-H2SO4) by the method of Fiske & Subbarow (1925) . The reaction was zero-order until 75% of the substrate had been converted. For some experiments, and always for those experiments where the enzyme was incubated in the absence of cysteine (and was therefore largely unbuffered), a final concentration of 4-2 mM-KHCO3 was added as 0-4ml. of 21mM-KHCO3 saturated with CO2+N2 (5:95) . Such an addition does not influence the inhibition by beryllium in the presence of cysteine. The time allowed for activation of the enzyme by cysteine and magnesium was never less than lmin. In the experiments described below the enzyme was often preincubated with MgSO4 or cysteine alone with or without BeSO4. In these cases a further Imin. with both MgSO4 and cysteine present was always allowed before the substrate was added. The concentrations of BeSO4 stated were always those during the preincubation, which was at 300 except where otherwise stated.
Most of the experiments were carried out with a partially purified phosphoglucomutase from rabbit muscle prepared as described by Thomas & Aldridge (1966) . The response of this preparation to cysteine and BeSO4 was identical with that of the crystalline preparation.
RESULTS
Complex-forming agents and inhibition by beryllium. Phosphoglucomutase requires magnesium, a complex-forming agent and glucose 1,6-diphosphate as coenzyme for maximal activity Robinson & Najjar, 1961; Sutherland, 1949; Cori, Colowick & Cori, 1938; Leloir, Trucco, Cardini, Paladini & Caputto, 1948; Cardini, Paladini, Caputto, Leloir & Trucco, 1949; Milstein, 1961b) . Since the enzyme as normally isolated is in the phosphoryl-enzyme form (Jagannathan & Luck, 1949; Najjar & Pullman, 1954) , no glucose 1,6-diphosphate, other than that in the glucose 1-phosphate, has been added. For most of the experiments described below cysteine has been used as the complex-forming agent because with our enzyme preparation this has given a higher activity than imidazole. In the absence of magnesium or cysteine or both the enzyme has no activity. Although Robinson & Najjar (1961) demonstrated that the activation of phosphoglucomutase by imidazole and magnesium was a time-dependent process and for full activation several minutes were required, we have been unable to demonstrate such a time-dependent activation with cysteine and magnesium. Full activity has always been obtained when cysteine and magnesium are present at 300; even with lower concentrations of cysteine or at 0°maximal activity was obtained with no preincubation. We conclude from these observations that cysteine is a more efficient activator than imidazole and the activation process is rapid. Since the concentration of cysteine in tissues is much less than that of glutathione (Bhattacharya, Robson & Stewart, 1955; Malathi, Seshadri Sastry & Ganguly, 1961; Thomson & Martin, 1959 ), glutathione has been tested as an activator of phosphoglucomutase (cf. Lehmann, 1939) . In the presence of glutathione an activity only 60% of that with cysteine can be obtained; the concentration for half-maximal activation is approx. 0-5mM for each compound.
In early experiments with phosphoglucomutase and beryllium it was found that little or no inhibition was obtained if cysteine was not present during the incubation with beryllium (Table 1) . Preincubation in the absence of cysteine and magnesium leads to only 7 % inhibition, whereas in the presence of 25mM-cysteine 80%o inhibition is obtained. Beryllium also inhibits with imidazole in the place of cysteine. If magnesium sulphate (1-5mM) is present with cysteine during the preincubation a 15-fold increase in the concentration of beryllium sulphate is required to give the same degree of inhibition.
Competition between beryllium and magnesium.
The following reactions take place in the activation by magnesium and inhibition by beryllium of phosphoglucomutase:
By using the steady-state kinetic analysis outlined in Dixon & Webb (1964, p. 429) , with the assumption that the activation by magnesium and the reaction of the enzyme with the substrate are independent of one another, it can be shown that:
where v is the velocity of reaction, VMg is the maximum velocity of reaction at a particular substrate concentration in the presence of magnesium and Kg, i.e. k-ll/k+, is the dissociation constant ofthe enzyme-magnesium complex. In the presence 
where the combination of enzyme with metal is reversible A equals k+2/k-2, i.e. l/Ki, the reciprocal of the dissociation constant of enzyme-inhibitor complex. As shown below, the reaction of phosphoglucomutase with beryllium is progressive (i.e. k12 tends towards 0) and is described by a velocity constant rather than an equilibrium constant. In these circumstances A equals k2, the bimolecular rate constant for the reaction of enzyme with beryllium. As shown in Fig. 1 Table 2 , the concentration of magnesium sulphate giving half maximum activity being 75 pM and the bimolecular rate constant for the reaction of enzyme with beryllium is 6-1 x 104 1. mole-1 min.-1. A value for KMg of approx. 50 tM has been obtained by Milstein (1961a) .
Progressive inhibition. When phosphoglucomutase is incubated with beryllium sulphate and cysteine for various times, the inhibition increases with time and shows the characteristics of a firstorder reaction (Fig. 1) . The bimolecular rate constants derived from these results are 7-2 x 104, obtained with a crystalline enzyme preparation. The calculation of such rate constants is only valid if the concentration of one component (beryllium) of the system is effectively constant. Calculation from a molecular activity of 12400mole-1min.-l of enzyme (Najjar, 1962) indicates an enzyme concentration of 0-013pUM, at least 200-300 times less than the concentration of beryllium sulphate.
Inhibition of enzymes by metal ions has usually been described by an equilibrium process (Dixon & Webb, 1964, p. 346) . In view of the lack of equilibrium with beryllium and phosphoglucomutase, the effect of the other constituents ofthe medium on the inhibitory process was determined. Milstein (1961b) has shown that thQ activation of phosphoglucomutase is a complex process and is partly due to removal of heavy-metal impurities. It was therefor essential to examine the influence of cysteine added at various times. If the enzyme is incubated with cysteine before a further incubation with beryllium, the progressive inhibition still occurs (Fig. 2) ; if the enzyme is incubated with beryllium in the absence of cysteine, little or no inhibition occurs. In Figs. 1, 2 and 3 the lines sometimes do not pass through 2-0 (loglO O%). This has been found to be somewhat variable between experiments; we have no explanation for it.
Since it has been shown above that the inhibition by beryllium is competitive with respect to magnesium, the effect of magnesium on the rate of inhibition has been examined. Again no inhibition is obtained if cysteine is omitted from the medium and the enzyme incubated with beryllium in the presence of magnesium (Fig. 3) . If the enzyme is preincubated with cysteine or (cysteine plus magnesium) before beryllium the progressive inhibition still occurs. The rate of inhibition in the presence of 1-8mM-magnesium sulphate and 40MM-beryllium sulphate is approximately the same as that with 2-7 1tM-beryllium sulphate in the absence of added magnesium (bimolecular rate constant 3-2 x 1031.mole-lmin.-l in the presence of 1-8mM-magnesium sulphate). Magnesium therefore slows down the rate of progressive inhibition. However, if the enzyme is inhibited by incubation with beryllium sulphate (2.7,um) and cysteine and then magnesium sulphate are added, no further inhibition occurs. This agrees with the slight inhibition expected by 2-7/tM-beryllium sulphate and 1-8mM-magnesium sulphate (calculated from arate constant of 3-2 x 1031.mole-lmin.-l this is only 8%). More important is the observation that the enzyme is not reactivated by the addition of magnesium sulphate.
From a few experiments at different temperatures (100, 200, 300, 370) the apparent energy of activation of the progressive inhibition by beryllium is 13 300 + 3200 (4) cal./mole. This is similar to the value of 14 200 + 780 (8) cal./mole for the enzymic process.
DISCUSSION
There are therefore two phenomena to be discussed. First, inhibition of phosphoglucomutase after incubation with beryllium requires the presence of a complex-forming agent (cysteine and imidazole); secondly, in the presence of a complexforming agent the inhibition is progressive, follows first-order kinetics and shows the characteristics of a bimolecular reaction with one component in excess.
Phosphoglucomutase requires for activation both magnesium and a complex-forming agent. It seems likely that the main function ofthe complex-forming agent (cysteine) is to remove heavy-metal inhibitors from the enzyme (Milstein, 1961a,b) so that magnesium can gain access. It is therefore probable that the requirement for cysteine to obtain inhibition by beryllium (Table 1 and Figs. 3 and 4) is the same. The inhibition by beryllium increases with time and it is important to know that this apparent slow inhibition is not due to a slow removal BeSO4 (40Mm, ; A, BeSO4 (2-7HtM) plus cysteine (0-5min.) , . Other conditions and controls are as stated in Fig. 3. of heavy metals from the enzyme. This cannot be so, since the activation by cysteine is rapid (cf. Table 1 ) and in other experiments has been shown to be complete in 15 sec. at 00. Further, incubation of the enzyme with cysteine for 5 min. at 300 (Figs. 3 and 4) , whether with or without magnesium, followed by the addition of beryllium sulphate, does not lead to an immediate rapid inhibition but to the progressive inhibition obtained without a preliminary incubation with cysteine. Therefore the progressive inhibition is due to a reaction between the active enzyme and beryllium and is not due to a progressive reaction induced by the other reagents present.
It seems probable that the initial attachment of beryllium to the enzyme is in principle the same process as the attachment of magnesium during the activation process; this conclusion is reinforced by the demonstration of competition between magnesium and beryllium. However, such a similarity between activation and inhibition gives no clue of the processes involved at a molecular level. It is unlikely that the processes of activation by magnesium and the progressive inhibition by beryllium are formally the same. The kinetics of the inhibitory process are identical with those of the inhibition of esterases by organophosphorus compounds (Aldridge, 1956) . By analogy with the reaction of enzyme with substrate it might be expected that there would be an intermediate ' esterase-organophosphate' complex before the formation of the phosphorylated enzyme. There is no direct evidence for such a complex with erythrocyte cholinesterase (Aldridge & Davison, 1952) , but for human serum cholinesterase and one organophosphorus compound an 'inhibitor-enzyme intermediate' has been claimed to have been detected (Main, 1964) . The inhibition of phosphoglucomutase by beryllium is analogous and there is no direct evidence of a two-or-more-stage process. For inhibition of esterases by organophosphorus compounds it is as though collision of inhibitor and enzyme in the right way leads directly to reaction to give a phosphorylated enzyme; it is possible that the inhibition of phosphoglucomutase by beryllium is similar and that the presence of magnesium merely lowers the probability of a 'fruitful' collision. Although the breakage and formation of the covalent bonds involved in the phosphorylation of esterases is compatible with an apparent energy of activation of 10-1 lkcal./mole (Aldridge, 1953) , a value of 13-14kcal./mole for the inhibition of phosphoglucomutase by beryllium is difficult to reconcile with a simple ionic interaction of enzyme and beryllium. If no other changes occur in the protein, then the beryllium must be attached by a covalent bond to the protein. There is evidence that beryllium can behave chemically in a somewhat anomalous manner (Pauling, 1948; Van Uitert, Fernelius & Douglas, 1953) ; it is therefore at present not possible to eliminate a combination of beryllium with enzyme by covalent bonds. However, temperature-dependent changes in the protein initiated by the primary attachment of beryllium (instead of magnesium), leading to an inactive enzyme, must be considered. Theoretically this change could be catalytic, for we have no conclusive evidence that beryllium is attached to the inhibited enzyme.
